Showing results (121-130 of 163) with videos related to
Sort By:
Pageof 17
RSC Advances|November 7, 2024
Design, synthesis, and evaluation of novel thiadiazole derivatives as potent VEGFR-2 inhibitors: a comprehensive in vitro and in silico studyIbrahim H Eissa, Walid E Elgammal, Hazem A Mahdy, et al.Plos One|January 27, 2025
Integrated in silico and in vitro exploration of the anti-VEGFR-2 activities of a semisynthetic xanthine alkaloid inhibiting breast cancerEslam B Elkaeed, Hazem Elkady, Ahmed M Khattab, et al.Bioorganic Chemistry|December 18, 2020
Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinomaIbrahim H Eissa, Mohammed K Ibrahim, Ahmed M Metwaly, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|December 28, 2021
New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studiesHazem Elkady, Alaa Elwan, Hesham A El-Mahdy, et al.Molecules (Basel, Switzerland)|July 9, 2022
Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2Reda G Yousef, Wagdy M Eldehna, Alaa Elwan, et al.Chemical Biology & Drug Design|July 21, 2025
New Thiadiazole-Benzenesulfonamide Hybrids as Dual B-Raf/VEGFR-2 Inhibitors With Promising Anti-Hepatic Cancer ActivityAisha A Alsfouk, Hazem Elkady, Saber M Hassan, et al.Journal of Biomolecular Structure & Dynamics|January 9, 2023
Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studiesMohammed S Taghour, Hazem Elkady, Wagdy M Eldehna, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|May 16, 2022
Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studiesReda G Yousef, Albaraa Ibrahim, Mohamed M Khalifa, et al.Bioorganic Chemistry|June 27, 2021
Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluationKhaled El-Adl, Helmy M Sakr, Reda G Yousef, et al.Future Medicinal Chemistry|November 14, 2024
Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducersReda G Yousef, Ibrahim H Eissa, Hazem Elkady, et al.Pageof 17